(Q22252218)

PubMed

PubMed publication ID

7 February 2023

Frank Jacobi

2

Frank

Jacobi

1 reference

PubMed

PubMed publication ID

15961293

European Neuropsychopharmacology

7 February 2023

language of work or name

English

0 references

publication date

August 2005

0 references

published in

0 references

volume

15

0 references

issue

4

0 references

page(s)

357-376

0 references

cites work

An Inventory for Measuring Depression

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

The Composite International Diagnostic Interview. An epidemiologic Instrument suitable for use in conjunction with different diagnostic systems and in different cultures

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

SCAN. Schedules for Clinical Assessment in Neuropsychiatry

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

An international study of psychological problems in primary care. Preliminary report from the World Health Organization Collaborative Project on 'Psychological Problems in General Health Care'.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

The cross-national epidemiology of panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 surveys' estimates

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Mild Disorders Should Not Be Eliminated From the DSM-V

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Cross-national epidemiology of major depression and bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Prevalence, Severity, and Unmet Need for Treatment of Mental Disorders in the World Health Organization World Mental Health Surveys

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Generalized anxiety disorder: prevalence, burden, and cost to society.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Estimating the prevalence of mental and somatic disorders in the community: aims and methods of the German National Health Interview and Examination Survey.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

The European Study of the Epidemiology of Mental Disorders (ESEMeD/MHEDEA 2000) project: rationale and methods.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

The US National Comorbidity Survey Replication (NCS-R): design and field procedures.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

The World Health Organization Composite International Diagnostic Interview short-form (CIDI-SF)

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Six-month prevalence of phobic symptoms in Iceland: an epidemiological postal survey

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

The Zurich study ?A prospective epidemiological study of depressive, neurotic and psychosomatic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

[Lifetime prevalence of mental disorders in general adult population. Results of TACOS study]

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Prevalence of psychiatric disorder in Europe: the potential and reality of meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Test-retest reliability of the computerized DSM-IV version of the Munich-Composite International Diagnostic Interview (M-CIDI).

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Prevalence of psychiatric disorder in the general population: results of The Netherlands Mental Health Survey and Incidence Study (NEMESIS).

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

DSM-IV mood-, anxiety- and alcohol use disorders and their comorbidity in the Finnish general population--results from the Health 2000 Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Gender differences in depression. Epidemiological findings from the European DEPRES I and II studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Obsessive-compulsive severity spectrum in the community: prevalence, comorbidity, and course

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Diagnosing major depression in the elderly: evidence for response bias in standardized diagnostic interviews?

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Reliability and validity studies of the WHO--Composite International Diagnostic Interview (CIDI): a critical review

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Size and burden of social phobia in Europe

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Prevalence of dementia in the elderly in Europe

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Problematic drug use and drug use disorders in EU countries and Norway: an overview of the epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Alcohol use disorders in EU countries and Norway: an overview of the epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

The epidemiology of panic disorder and agoraphobia in Europe

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Prevalence and incidence of Parkinson's disease in Europe

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Size and burden of depressive disorders in Europe

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Size of burden of schizophrenia and psychotic disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

The epidemiology of generalized anxiety disorder in Europe

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Prevalence and burden of bipolar disorders in European countries.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

The sensitivity and specificity of the Major Depression Inventory, using the Present State Examination as the index of diagnostic validity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Anxiety disorders comorbidity in bipolar I, bipolar II and unipolar major depression: results from a population-based study in Hungary

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

What depressive symptoms are associated with the use of care services? Results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS).

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

The prevalence of affective and anxiety disorders in primary care practice in Hungary.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

The prevalence of major depressive and bipolar disorders in Hungary. Results from a national epidemiologic survey.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Comorbidity of substance use disorders with mood and anxiety disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Prevalence and age of onset for drug use in seven international sites: results from the international consortium of psychiatric epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Measuring psychiatric disorder in the community: a standardized assessment for use by lay interviewers

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS).

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

The impact of psychiatric disorders on work loss days

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

The National Psychiatric Morbidity surveys of Great Britain--initial findings from the household survey.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

The National Psychiatric Morbidity surveys of Great Britain--strategy and methods

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Prevalence of mental disorders and psychosocial impairments in adolescents and young adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Prevalence of suicide ideation and suicide attempts in nine countries

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Current and residual functional disability associated with psychopathology: findings from the Netherlands Mental Health Survey and Incidence Study (NEMESIS).

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

The 12-month prevalence and risk factors for major depressive episode in Finland: representative sample of 5993 adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Prevalence of major depression and stress indicators in the Danish general population.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

The burden of brain diseases in Europe

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Gender differences in major depressive disorder in a Hungarian community survey

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Depression in the community: results of the first Italian survey.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

The Diagnostic Screening Procedure Writer. A tool to develop individualized screening procedures.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Cost of disorders of the brain in Europe

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Disability and quality of life impact of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Use of mental health services in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Lifetime prevalence of specific mental disorders among people born in Iceland in 1931.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

The lifetime prevalence of anxiety disorders in Iceland as estimated by the US National Institute of Mental Health Diagnostic Interview Schedule

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Functional disability and depression in the general population. Results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS).

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Evidence-Based Health Policy---Lessons from the Global Burden of Disease Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

The Early Developmental Stages of Psychopathology Study (EDSP): A Methodological Update

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Continued needs for epidemiological studies of mental disorders in the community.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

The Sesto Fiorentino study: point and one-year prevalences of psychiatric disorders in an Italian community sample using clinical interviewers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

A Norwegian psychiatric epidemiological study

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Outcomes of Depression International Network (ODIN). Background, methods and field trials. ODIN Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Adolescents' self-reported problems as predictors of psychopathology in adulthood: 10-year follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Depressive disorders in Europe: prevalence figures from the ODIN study

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Prevalence of psychiatric disorder and the need for psychiatric care in Northern Ireland. Population study in the District of Derry.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

The prevalence of treated and untreated mental disorders in five countries

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

Psychiatric morbidity, service use, and need for care in the general population: results of The Netherlands Mental Health Survey and Incidence Study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021

The economic burden of anxiety disorders in the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2005.04.012

7 January 2021